PlainRecalls
FDA Drug Moderate Class II Terminated

SUCCINYLcholine Chloride 200 mg/10mL (20 mg/mL), 10 mL BD Syringe, Rx Only, Advanced Compounding Solutions, 4 Constitution Way Ste L Woburn, MA 01801-1042; NDC: 71546-083-10

Reported: July 26, 2023 Initiated: July 10, 2023 #D-0926-2023

Product Description

SUCCINYLcholine Chloride 200 mg/10mL (20 mg/mL), 10 mL BD Syringe, Rx Only, Advanced Compounding Solutions, 4 Constitution Way Ste L Woburn, MA 01801-1042; NDC: 71546-083-10

Reason for Recall

CGMP Violations- that spaces adjacent to the production area may have been compromised at the time of production.

Details

Units Affected
493 syringes
Distribution
Nationwide in the USA
Location
Woburn, MA

Frequently Asked Questions

What product was recalled?
SUCCINYLcholine Chloride 200 mg/10mL (20 mg/mL), 10 mL BD Syringe, Rx Only, Advanced Compounding Solutions, 4 Constitution Way Ste L Woburn, MA 01801-1042; NDC: 71546-083-10. Recalled by New England Life Care, Inc. dba Advanced Compounding Solutions. Units affected: 493 syringes.
Why was this product recalled?
CGMP Violations- that spaces adjacent to the production area may have been compromised at the time of production.
Which agency issued this recall?
This recall was issued by the FDA Drug on July 26, 2023. Severity: Moderate. Recall number: D-0926-2023.